Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c

Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Fed's Hammack sees inflation at 3% by year-end, mid-twos in 2027
• Active options: AMZN META SOFI PBR CRWD AMD MRVL IREN BMNR